Wu CC - Search Results

1

Intranasal Vaccination With Recombinant Antigen-FLIPr Fusion Protein Alone Induces Long-Lasting Systemic Antibody Responses and Broad T Cell Responses.

Hsieh MS, Hsu CW, Tu LL, Chai KM, Yu LL, Wu CC, Chen MY, Chiang CY, Liu SJ, Liao CL, Chen HW. Hsieh MS, et al. Among authors: wu cc. Front Immunol. 2021 Oct 11;12:751883. doi: 10.3389/fimmu.2021.751883. eCollection 2021. Front Immunol. 2021. PMID: 34707615 Free PMC article.

2

Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy.

Chang LS, Leng CH, Yeh YC, Wu CC, Chen HW, Huang HM, Liu SJ. Chang LS, et al. Among authors: wu cc. Mol Cancer. 2014 Mar 19;13:60. doi: 10.1186/1476-4598-13-60. Mol Cancer. 2014. PMID: 24642245 Free PMC article.

3

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.

Wu CC, Liu SJ, Chen HW, Shen KY, Leng CH. Wu CC, et al. Oncotarget. 2016 May 24;7(21):30804-19. doi: 10.18632/oncotarget.9001. Oncotarget. 2016. PMID: 27127171 Free PMC article.

4

A novel liposomal recombinant lipoimmunogen enhances anti-tumor immunity.

Shen KY, Liu HY, Li HJ, Wu CC, Liou GG, Chang YC, Leng CH, Liu SJ. Shen KY, et al. Among authors: wu cc. J Control Release. 2016 Jul 10;233:57-63. doi: 10.1016/j.jconrel.2016.05.008. Epub 2016 May 6. J Control Release. 2016. PMID: 27164542

5

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.

Chiang CY, Chen YJ, Wu CC, Liu SJ, Leng CH, Chen HW. Chiang CY, et al. Among authors: wu cc. Front Immunol. 2018 Apr 23;9:822. doi: 10.3389/fimmu.2018.00822. eCollection 2018. Front Immunol. 2018. PMID: 29755461 Free PMC article.

6

Delivery of Antigen to CD8⁺ Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity.

Chiang CY, Wu CC, Chen YJ, Liu SJ, Leng CH, Chen HW. Chiang CY, et al. Among authors: wu cc. Front Immunol. 2019 Aug 2;10:1839. doi: 10.3389/fimmu.2019.01839. eCollection 2019. Front Immunol. 2019. PMID: 31428106 Free PMC article.

7

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells.

Shen KY, Liu HY, Yan WL, Wu CC, Lee MH, Leng CH, Liu SJ. Shen KY, et al. Among authors: wu cc. Cancers (Basel). 2020 Mar 28;12(4):810. doi: 10.3390/cancers12040810. Cancers (Basel). 2020. PMID: 32231003 Free PMC article.

8

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice.

Chen MY, Chai KM, Chiang CY, Wu CC, Yu GY, Liu SJ, Chen HW. Chen MY, et al. Among authors: wu cc. J Biomed Sci. 2020 Apr 14;27(1):51. doi: 10.1186/s12929-020-00646-x. J Biomed Sci. 2020. PMID: 32290844 Free PMC article.

9

A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment.

Wu CC, Chiang CY, Liu SJ, Chen HW. Wu CC, et al. Biomedicines. 2021 Jul 12;9(7):806. doi: 10.3390/biomedicines9070806. Biomedicines. 2021. PMID: 34356870 Free PMC article.

10

Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment.

Yan WL, Wu CC, Shen KY, Liu SJ. Yan WL, et al. Among authors: wu cc. J Immunother Cancer. 2021 Oct;9(10):e002758. doi: 10.1136/jitc-2021-002758. J Immunother Cancer. 2021. PMID: 34599024 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,574 results

Search Page

Filters